2016
DOI: 10.1016/j.phrs.2016.01.007
|View full text |Cite
|
Sign up to set email alerts
|

Are NHE1 and inducible nitric oxide synthase involved in human ovarian cancer?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 16 publications
(28 reference statements)
0
1
0
Order By: Relevance
“…NHE1 can facilitate the EMT progress and contribute to invasion and metastasis [21][22][23]. In consistent, elevated expression of NHE1 was observed in many types of cancers, including breast cancer [21], gastric cancer [23] and ovarian cancer [24]. Since SK can inhibit aerobic glycolysis, it is rational that SK may has regulatory effect on NHE1 expression, and subsequently effluence the EMT in cancer cells.…”
Section: Introductionmentioning
confidence: 93%
“…NHE1 can facilitate the EMT progress and contribute to invasion and metastasis [21][22][23]. In consistent, elevated expression of NHE1 was observed in many types of cancers, including breast cancer [21], gastric cancer [23] and ovarian cancer [24]. Since SK can inhibit aerobic glycolysis, it is rational that SK may has regulatory effect on NHE1 expression, and subsequently effluence the EMT in cancer cells.…”
Section: Introductionmentioning
confidence: 93%